5 participants
Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-05
- Start Date:
- 2024-03-28
- Completion:
- 2025-09-25
Conditions
- Acute Myeloid Leukemia
- Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Relapse Leukemia
- Refractory Leukemia
Interventions
- BIOLOGICAL
No Results Yet